Wilmington, Delaware, Oct. 06, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Bio Pharma Buffer Market by Buffer Type (Phosphates Type, Acetates Type, Tris Type and Others), by Application (Protein Purification, Cell Culture, Formulation, Chromatography, Biosensors and Others), and End User (Research Institution, Pharmaceutical Industry and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the bio pharma buffer market was valued at $1.1 billion in 2023, and is estimated to reach $2.4 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.
Request Sample of the Report on Bio Pharma Buffer Market 2033 - https://www.alliedmarketresearch.com/request-sample/A324376
Prime Determinants of Growth
The market for bio pharma buffer is primarily driven by the rise in demand for the biopharmaceuticals products, growing biopharmaceutical industry and strict regulatory framework which ensure product quality and safety. Increasing demand for biopharmaceuticals, driven by advancements in biotechnology and healthcare needs, propels the need for high-quality buffers used in various stages of drug development and manufacturing. These buffers play critical roles in maintaining pH levels, stabilizing proteins, and controlling reactions during biopharmaceutical production processes, thereby ensuring product efficacy and safety. Moreover, stringent regulatory requirements mandating the use of buffers that comply with Good Manufacturing Practices (GMP) further fuel market growth, as companies strive to meet global standards and ensure product quality and consistency.
Additionally, the expanding biopharmaceutical pipeline, characterized by a rising number of complex therapies such as monoclonal antibodies and gene therapies, drives innovation and specialization in buffer formulations. This diversification in therapeutic modalities necessitates tailored buffer solutions capable of supporting the unique requirements of different biopharmaceutical products. Furthermore, the trend towards outsourcing of biopharmaceutical manufacturing activities to contract manufacturing organizations (CMOs) drives demand for buffers, as contract manufacturing organizations seek reliable suppliers capable of providing consistent, high-quality buffer systems.
Report Coverage & Details
| Repot Coverage | Details |
| Forecast Period | 2024–2033 |
| Base Year | 2023 |
| Market Size in 2023 | $1.1 billion |
| Market Size in 2033 | $2.4 billion |
| CAGR | 7.8% |
| No. of Pages in Report | 280 |
| Segments Covered | Buffer Type, Application, End User and Region |
| Drivers |
|
| Opportunities |
|
| Restraint |
|
Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A324376
Segment Highlights
The phosphates type segment dominated market share in 2023
By buffer type, phosphates type segment dominated the market share in 2023. This is attributed to the fact that phosphates are widely recognized for their buffering capacity across a broad pH range, making them versatile and suitable for a variety of biopharmaceutical applications. This versatility is crucial in the biopharma industry where buffers must maintain stable pH levels to ensure the integrity and activity of biological molecules such as proteins and enzymes. In addition, phosphates offer excellent solubility and compatibility with many biological systems, minimizing the risk of interference or adverse reactions with sensitive biomolecules. This makes them reliable choices for buffer solutions used in research, development, and manufacturing processes within the biopharma sector.
Formulation segment dominated the market share in 2023
By application, formulation segment dominated the market share in 2023. This is attributed to the fact that Formulation buffers are essential in maintaining the stability, solubility, and efficacy of biopharmaceutical products throughout their lifecycle. They are specifically designed to optimize the pH, osmolarity, and ionic strength of drug formulations, ensuring that active ingredients remain stable and bioavailable.
Pharmaceutical industry segment dominated market share in 2023
By end user, pharmaceutical industry segment dominated the market share in 2023. This is attributed to the fact that pharmaceutical companies are increasingly focusing on biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins, which require precise buffering solutions throughout their production processes. Buffers play a critical role in maintaining the stability and activity of biomolecules during various stages of biopharmaceutical manufacturing, ensuring product efficacy and safety. As the demand for biopharmaceuticals continues to rise globally due to growing healthcare needs and advancements in biotechnology there is a surge In demand of buffers.
Regional Outlook
North America holds a dominant position in the market, attributed to high adoption of the bio pharma buffer by biopharmaceutical companies, well-established biopharmaceutical sector, and high adoption of biologics for effective treatment of chronic diseases. However, Asia-Pacific region is expected to register highest CAGR in the forecast period. This is attributed to expanding healthcare infrastructure, increasing investments in biotechnology, and rising healthcare expenditure in countries like China, India, and Japan.
For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A324376
Key Players
- Becton Dickinson and Company
- Cardinal Health
- Techcon Systems
- Thermo Fisher Scientific
- Masterflex
- Quality Lab Accessories
- Charles River Laboratories
- Avanos Medical
- Conmed
- Accutome
The report provides a detailed analysis of these key players in the global bio pharma buffer market. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Trending Reports in Healthcare Industry:
Nanomedicine Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Regenerative Medicine Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Brain Health Supplements Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Surgical Imaging Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
